Back

Cell-to-cell heterogeneities during extrinsic apoptosis arise from cell cycle progression and transmitotic apoptosis resistance

Pollak, N.; Lindner, A.; Imig, D.; Kuritz, K.; Fritze, J. S.; Heinrich, I.; Stadager, J.; Eisler, S. A.; Stöhr, D.; Allgöwer, F.; Scheurich, P.; Morrison (Rehm), M.

2021-02-27 cell biology
10.1101/2021.02.26.433034 bioRxiv
Show abstract

Extrinsic apoptosis relies on TNF-family receptor activation by immune cells or receptor-activating biologics. Here, we monitored cell cycle progression at minutes resolution to relate apoptosis kinetics and cell-to-cell heterogeneities in death decisions to cell cycle phases. Interestingly, we found that cells in S phase delay TRAIL receptor-induced death in favour for mitosis, thereby passing on an apoptosis-primed state to their offspring. This translates into two distinct fates, apoptosis execution post mitosis or cell survival from inefficient apoptosis. Transmitotic resistance is linked to Mcl-1 upregulation from mid S phase onwards, which allows cells to pass through mitosis with activated caspase-8, and with cells escaping apoptosis after mitosis sustaining sublethal DNA damage. Antagonizing Mcl-1 by BH3-mimetics suppresses cell cycle-dependent delays in apoptosis, prevents apoptosis-resistant progression through mitosis and averts unwanted survival from apoptosis induction. Cell cycle progression therefore modulates signal transduction during extrinsic apoptosis, with Mcl-1 governing decision making between death, proliferation and survival from inefficient apoptosis induction. Cell cycle progression thus is a crucial process from which cell-to-cell heterogeneities in fates and treatment outcomes emerge in isogenic cell populations during extrinsic apoptosis signalling.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Cell Death & Disease
126 papers in training set
Top 0.1%
39.7%
2
Cell Death & Differentiation
48 papers in training set
Top 0.1%
18.6%
50% of probability mass above
3
Cell Death Discovery
58 papers in training set
Top 0.1%
4.9%
4
EMBO Reports
263 papers in training set
Top 0.9%
4.3%
5
eLife
5828 papers in training set
Top 29%
4.1%
6
Science Signaling
65 papers in training set
Top 0.3%
3.3%
7
Journal of Biological Chemistry
690 papers in training set
Top 3%
3.2%
8
Science Advances
1243 papers in training set
Top 16%
2.1%
9
Nature Communications
5641 papers in training set
Top 45%
1.7%
10
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 27%
1.7%
11
iScience
1154 papers in training set
Top 22%
1.3%
12
Journal of Cell Biology
392 papers in training set
Top 3%
1.1%
13
Oncogene
85 papers in training set
Top 1%
1.1%
14
Cells
249 papers in training set
Top 5%
1.1%
15
Life Science Alliance
285 papers in training set
Top 7%
0.8%
16
The EMBO Journal
309 papers in training set
Top 6%
0.8%
17
Journal of Cell Science
393 papers in training set
Top 5%
0.6%
18
Nucleic Acids Research
1281 papers in training set
Top 15%
0.6%
19
Molecular Cancer Research
49 papers in training set
Top 1%
0.6%
20
Molecular Cancer Therapeutics
40 papers in training set
Top 1.0%
0.6%
21
Cancer Discovery
66 papers in training set
Top 2%
0.6%
22
Molecular Oncology
55 papers in training set
Top 2%
0.6%